FDA approves daraxonrasib as Elicio preps Phase 1 trial combining it with camupepimutNov 6Regulatory decisiondaraxonrasibElicio TherapeuticsUpdated
Elicio reports Q2 2026 results, plans new Phase 1 combination trial after complete responsesAug 13Quarterly updateElicio Therapeutics